HOME | Alphawatch

top of page

Stock Exchange

GLP-1s are All the Rage - Let's Dig Into That

GLP-1s are All the Rage - Let's Dig Into That

GLP-1s are All the Rage - Let's Dig Into That

Jonathan Poyer

1 hour ago2 min read

Lilly (LLY) Paying $2.9B for a Phase 1 Biotech Merida Biosciences

Lilly (LLY) Paying $2.9B for a Phase 1 Biotech Merida Biosciences

Lilly (LLY) Paying $2.9B for a Phase 1 Biotech Merida Biosciences

Jonathan Poyer

1 hour ago2 min read

When the Shock Absorber Stops Absorbing

When the Shock Absorber Stops Absorbing

When the Shock Absorber Stops Absorbing

Jonathan Poyer

1 day ago4 min read

What are the Medical & Investment Implication of Psychedelics

What are the Medical & Investment Implication of Psychedelics

What are the Medical & Investment Implication of Psychedelics

Jonathan Poyer

1 day ago1 min read

Globus Medical (GMED) Adds AI to Its Surgical Ecosystem

Globus Medical (GMED) Adds AI to Its Surgical Ecosystem

Globus Medical (GMED) Adds AI to Its Surgical Ecosystem

Jonathan Poyer

1 day ago1 min read

Synopsys (SNPS): AI Demand Is Showing Up in the Numbers

Synopsys (SNPS): AI Demand Is Showing Up in the Numbers

Synopsys (SNPS): AI Demand Is Showing Up in the Numbers

Jonathan Poyer

6 days ago1 min read

BioMarin (BMRN) Makes a $275 Million Bet on an Oral Treatment for Rare Bone Disease

BioMarin (BMRN) Makes a $275 Million Bet on an Oral Treatment for Rare Bone Disease

BioMarin (BMRN) Makes a $275 Million Bet on an Oral Treatment for Rare Bone Disease

Jonathan Poyer

6 days ago1 min read

Gilead (GILD): Don't Let a $(8.45) EPS Number Obscure a +10% Quarter

Gilead (GILD): Don't Let a $(8.45) EPS Number Obscure a +10% Quarter

Gilead (GILD): Don't Let a $(8.45) EPS Number Obscure a +10% Quarter

Jonathan Poyer

Aug 271 min read

Argenx (ARGX) Looks Beyond FcRn with $2.2 Billion Acquisition of Forte Biosciences

Argenx (ARGX) Looks Beyond FcRn with $2.2 Billion Acquisition of Forte Biosciences

Argenx (ARGX) Looks Beyond FcRn with $2.2 Billion Acquisition of Forte Biosciences

Jonathan Poyer

Aug 241 min read

Jazz Pharmaceuticals (JAZZ) Deepens Its Rare Epilepsy Pipeline with Actio Biosciences Acquisition

Jazz Pharmaceuticals (JAZZ) Deepens Its Rare Epilepsy Pipeline with Actio Biosciences Acquisition

Jazz Pharmaceuticals (JAZZ) Deepens Its Rare Epilepsy Pipeline with Actio Biosciences Acquisition

Jonathan Poyer

Aug 241 min read

Ondas (ONDS) Adds More Manufacturing Muscle — and Another Company to Integrate

Ondas (ONDS) Adds More Manufacturing Muscle — and Another Company to Integrate

Ondas (ONDS) Adds More Manufacturing Muscle — and Another Company to Integrate

Jonathan Poyer

Aug 241 min read

Red Cat (RCAT): The Growth Is Here. Now Comes the Execution Test.

Red Cat (RCAT): The Growth Is Here. Now Comes the Execution Test.

Red Cat (RCAT): The Growth Is Here. Now Comes the Execution Test.

Jonathan Poyer

Aug 191 min read

bottom of page